Verition Fund Management
BCYC

Verition Fund Management’s Bicycle Therapeutics BCYC Stock Holding History

Verition Fund Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-280,327
Closed -$3.92M – 3332
2024
Q4 		$3.92M Buy
280,327
+68,176
+32% +$1.46M 0.02% 1062
2024
Q3 		$4.8M Sell
212,151
-54,598
-20% -$1.26M 0.02% 877
2024
Q2 		$5.4M Sell
266,749
-74,117
-22% -$1.67M 0.03% 689
2024
Q1 		$8.49M Sell
340,866
-399,673
-54% -$8.49M 0.06% 392
2023
Q4 		$13.4M Sell
740,539
-175,843
-19% -$2.91M 0.1% 174
2023
Q3 		$18.4M Buy
916,382
+237,370
+35% +$5.43M 0.21% 103
2023
Q2 		$17.3M Buy
679,012
+96,454
+17% +$2.24M 0.23% 102
2023
Q1 		$12.4M Buy
582,558
+201,709
+53% +$5.06M 0.17% 153
2022
Q4 		$11.3M Buy
380,849
+32,336
+9% +$867K 0.18% 128
2022
Q3 		$8.11M Sell
348,513
-50,510
-13% -$1.2M 0.09% 262
2022
Q2 		$6.7M Buy
399,023
+264,819
+197% +$5.58M 0.13% 183
2022
Q1 		$5.89M Sell
134,204
-30,511
-19% -$1.42M 0.07% 315
2021
Q4 		$10M Sell
164,715
-14,546
-8% -$803K 0.07% 168
2021
Q3 		$7.46M Sell
179,261
-32,613
-15% -$1.14M 0.06% 198
2021
Q2 		$6.43M Sell
211,874
-28,260
-12% -$854K 0.06% 197
2021
Q1 		$7.17M Buy
240,134
+206,300
+610% +$5.32M 0.08% 148
2020
Q4 		$607K Buy
33,834
+2,803
+9% +$54.1K 0.01% 617
2020
Q3 		$591K Buy
+31,031
New +$548K 0.01% 514

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Verition Fund Management's BCYC Position: Q1 2025 in Review

Verition Fund Management sold out of Bicycle Therapeutics (BCYC) in Q1 2025, closing a stake of 280,327 shares — an estimated $3.92M sold.

Verition Fund Management first reported a position in BCYC in Q3 2020 and held it in 18 quarters. The position peaked at $18.4M in Q3 2023. 95 funds tracked by Wall St. Rank hold BCYC as of Q1 2025.

  • Verition Fund Management reported no remaining Bicycle Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 280,327 Bicycle Therapeutics shares in Q1 2025, an estimated $3.92M.
  • Verition Fund Management first reported a position in Bicycle Therapeutics in Q3 2020 and held it in 18 quarters.
  • Verition Fund Management's Bicycle Therapeutics position peaked at $18.4M in Q3 2023.
  • 95 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.